X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (16070) 16070
Newsletter (133) 133
Magazine Article (120) 120
Book Chapter (22) 22
Newspaper Article (18) 18
Book / eBook (15) 15
Web Resource (11) 11
Dissertation (7) 7
Conference Proceeding (4) 4
Journal / eJournal (3) 3
Publication (2) 2
Transcript (2) 2
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14256) 14256
staphylococcal infections - epidemiology (9007) 9007
staphylococcal infections - microbiology (7309) 7309
female (7066) 7066
male (6497) 6497
staphylococcus aureus (5848) 5848
infectious diseases (5536) 5536
microbiology (4257) 4257
middle aged (4148) 4148
adult (4129) 4129
epidemiology (3569) 3569
aged (3454) 3454
staphylococcus aureus - isolation & purification (3276) 3276
methicillin resistance (3220) 3220
staphylococcus aureus - drug effects (3148) 3148
prevalence (3076) 3076
methicillin-resistant staphylococcus aureus - isolation & purification (2994) 2994
staphylococcal infections - drug therapy (2982) 2982
risk factors (2961) 2961
infections (2951) 2951
cross infection - epidemiology (2794) 2794
microbial sensitivity tests (2522) 2522
adolescent (2458) 2458
anti-bacterial agents - therapeutic use (2387) 2387
mrsa (2376) 2376
anti-bacterial agents - pharmacology (2338) 2338
animals (2321) 2321
child (2291) 2291
cross infection - microbiology (2231) 2231
staphylococcus aureus infections (2157) 2157
retrospective studies (2115) 2115
health aspects (2097) 2097
methicillin-resistant staphylococcus aureus (2008) 2008
staphylococcus aureus - genetics (1911) 1911
staphylococcal infections - prevention & control (1889) 1889
staphylococcal infections (1874) 1874
drug resistance in microorganisms (1846) 1846
child, preschool (1828) 1828
infection (1805) 1805
hospitals (1756) 1756
infant (1752) 1752
aged, 80 and over (1750) 1750
incidence (1658) 1658
methicillin-resistant staphylococcus aureus - genetics (1657) 1657
staphylococcus infections (1627) 1627
infant, newborn (1534) 1534
antibiotics (1504) 1504
staphylococcal infections - diagnosis (1495) 1495
strains (1471) 1471
public, environmental & occupational health (1469) 1469
nosocomial infections (1458) 1458
bacteremia (1452) 1452
colonization (1414) 1414
methicillin-resistant staphylococcus aureus - drug effects (1361) 1361
drug resistance (1335) 1335
young adult (1313) 1313
methicillin-resistant (1309) 1309
research (1298) 1298
community-acquired infections - microbiology (1293) 1293
immunology (1283) 1283
community-acquired infections - epidemiology (1274) 1274
cross infection - prevention & control (1236) 1236
genotype (1232) 1232
prospective studies (1228) 1228
cross infection (1207) 1207
mortality (1175) 1175
analysis (1171) 1171
staphylococcus aureus - classification (1154) 1154
staphylococcal infections - transmission (1144) 1144
molecular epidemiology (1107) 1107
carrier state - microbiology (1099) 1099
staphylococcal infections - veterinary (1097) 1097
risk-factors (1086) 1086
bacteria (1058) 1058
biochemical phenomena, metabolism, and nutrition (1043) 1043
research article (1043) 1043
infectious disease (1005) 1005
carrier state - epidemiology (999) 999
bacterial infections and mycoses (994) 994
bacteremia - microbiology (961) 961
infection control (954) 954
pharmacology & pharmacy (951) 951
methicillin (949) 949
electrophoresis, gel, pulsed-field (942) 942
surgery (923) 923
children (920) 920
resistant staphylococcus-aureus (914) 914
medicine (908) 908
genes (895) 895
surveillance (886) 886
methicillin-resistant staphylococcus aureus - classification (882) 882
drug resistance, bacterial (877) 877
skin (877) 877
bacteremia - epidemiology (863) 863
medicine, general & internal (845) 845
vancomycin (845) 845
pediatrics (842) 842
disease outbreaks (836) 836
staphylococcus (831) 831
bacterial proteins - genetics (813) 813
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (11) 11
Gerstein Science - Stacks (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Gerstein Science - Periodical Stacks (2) 2
Gerstein Science - Bindery (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (15389) 15389
Spanish (292) 292
French (261) 261
German (194) 194
Japanese (146) 146
Russian (118) 118
Portuguese (109) 109
Italian (56) 56
Polish (54) 54
Dutch (45) 45
Chinese (33) 33
Turkish (27) 27
Romanian (26) 26
Danish (24) 24
Czech (20) 20
Norwegian (20) 20
Hungarian (13) 13
Swedish (13) 13
Finnish (8) 8
Bulgarian (7) 7
Ukrainian (6) 6
Hebrew (4) 4
Korean (4) 4
Croatian (2) 2
Serbian (2) 2
Icelandic (1) 1
Lithuanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal
Burns, ISSN 0305-4179, 2017, Volume 43, Issue 3, pp. 642 - 653
Highlights • Burn depth/agent increases risk of developing an infection. • Infections found folliculitis, burn wound, urinary tract, pneumonia, CVC and bloodstream... 
Critical Care | Nosocomial infection | Burn wound infection | Pneumonia | Urinary tract infection | Health care related infection | Burns | URINARY-TRACT-INFECTION | MORTALITY | SURGERY | RISK-FACTORS | DERMATOLOGY | REPLACEMENT | BACTERIOLOGY | CATHETERS | INTENSIVE-CARE-UNIT | SURVEILLANCE | ASSOCIATION | BLOOD-STREAM INFECTIONS | CRITICAL CARE MEDICINE | Escherichia coli | Humans | Middle Aged | Child, Preschool | Male | Young Adult | Folliculitis - epidemiology | Aged, 80 and over | Urinary Tract Infections - microbiology | Catheter-Related Infections - epidemiology | Child | Infant, Newborn | Staphylococcus aureus | Escherichia coli Infections - drug therapy | Bacteremia - drug therapy | Pseudomonas Infections - microbiology | Wound Infection - epidemiology | Catheter-Related Infections - drug therapy | Drug Resistance, Microbial | Escherichia coli Infections - epidemiology | Acinetobacter baumannii | Catheter-Related Infections - microbiology | Adolescent | Bacteremia - epidemiology | Infant | Bacteremia - microbiology | Cephalosporins - therapeutic use | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Adult | Female | Pseudomonas aeruginosa | Staphylococcal Infections - microbiology | Wound Infection - drug therapy | Acinetobacter Infections - microbiology | Staphylococcal Infections - drug therapy | Colombia - epidemiology | Klebsiella Infections - drug therapy | Central Venous Catheters | Pneumonia - epidemiology | Pseudomonas Infections - drug therapy | Acinetobacter Infections - drug therapy | Escherichia coli Infections - microbiology | Folliculitis - microbiology | Pneumonia - microbiology | Klebsiella Infections - microbiology | Oxacillin - therapeutic use | Burns - epidemiology | Urinary Tract Infections - drug therapy | Urinary Tract Infections - epidemiology | Pneumonia - drug therapy | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Acinetobacter Infections - epidemiology | Wound Infection - microbiology | Aged | Folliculitis - drug therapy | Klebsiella pneumoniae | Development and progression | Burns and scalds | Surgery, Plastic | Health aspects | Staphylococcus aureus infections | Analysis | Bacterial pneumonia | Mortality | Urinary tract infections | Bacteria | Disease susceptibility | Antibacterial agents
Journal Article
American journal of respiratory and critical care medicine, ISSN 1535-4970, 2016, Volume 193, Issue 5, pp. 504 - 515
Rationale: Cystic fibrosis (CF) is characterized by early structural lung disease caused by pulmonary infections... 
Healthy controls | Cystic fibrosis | Microbiota | Nasopharynx | Longitudinal | microbiota | SMALL-COLONY VARIANTS | CARRIAGE | HAEMOPHILUS-INFLUENZAE | COMMUNITIES | CHILDREN | STREPTOCOCCUS-PNEUMONIAE | INHIBITION | RESPIRATORY SYSTEM | cystic fibrosis | INFLAMMATION | LUNG-DISEASE | STAPHYLOCOCCUS-AUREUS | longitudinal | nasopharynx | healthy controls | CRITICAL CARE MEDICINE | Carrier State - epidemiology | Streptococcus mitis - genetics | Prospective Studies | Humans | Corynebacterium Infections - epidemiology | Carrier State - microbiology | Haemophilus Infections - epidemiology | Infant | Male | Corynebacterium Infections - microbiology | Case-Control Studies | Anti-Bacterial Agents - therapeutic use | Enterobacteriaceae Infections - epidemiology | Female | Staphylococcal Infections - microbiology | Nasopharynx - microbiology | Real-Time Polymerase Chain Reaction | Burkholderia Infections - microbiology | Haemophilus Infections - drug therapy | Infant, Newborn | Staphylococcus aureus - genetics | Moraxellaceae Infections - epidemiology | Streptococcal Infections - microbiology | Burkholderia - genetics | Staphylococcal Infections - drug therapy | Burkholderia Infections - epidemiology | Cystic Fibrosis - microbiology | Enterobacteriaceae Infections - microbiology | Enterobacteriaceae - genetics | Moraxellaceae Infections - microbiology | Streptococcal Infections - epidemiology | Haemophilus influenzae - genetics | Corynebacterium - genetics | Cystic Fibrosis - epidemiology | Moraxellaceae Infections - drug therapy | DNA, Bacterial - genetics | Staphylococcal Infections - epidemiology | Corynebacterium Infections - drug therapy | Microbiota - genetics | Burkholderia Infections - drug therapy | Haemophilus Infections - microbiology | RNA, Ribosomal, 16S - genetics | Streptococcal Infections - drug therapy | Moraxella - genetics | Cohort Studies | Enterobacteriaceae Infections - drug therapy
Journal Article
Burns, ISSN 0305-4179, 2017, Volume 43, Issue 1, pp. 144 - 148
Highlights • Gram-positive organisms accounted for 66.4% of the causative pathogens for bloodstream infections (BSIs... 
Critical Care | Burn | Pediatric burn patients | Burn-associated bloodstream infections | Children | SURGERY | Burn-associated bloodstream | PERFORMANCE | COLONIZATION | SKIN CULTURES | IDENTIFICATION | DERMATOLOGY | VITEK 2 | infections | SURVEILLANCE | CRITICAL CARE MEDICINE | Anti-Infective Agents - pharmacology | Humans | Candidiasis - epidemiology | Child, Preschool | Infant | Male | Candidiasis - microbiology | Bacteremia - microbiology | Gram-Negative Bacterial Infections - microbiology | Microbial Sensitivity Tests | Klebsiella Infections - epidemiology | Time Factors | Gram-Positive Bacterial Infections - microbiology | Female | Staphylococcal Infections - microbiology | Catheter-Related Infections - epidemiology | Child | Acinetobacter Infections - microbiology | Central Venous Catheters | Risk Factors | Burns - microbiology | Escherichia coli Infections - microbiology | Catheterization, Central Venous | Klebsiella Infections - microbiology | Fungemia - microbiology | Pseudomonas Infections - microbiology | Burns - epidemiology | Gram-Positive Bacterial Infections - epidemiology | Drug Resistance, Microbial | Escherichia coli Infections - epidemiology | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Turkey - epidemiology | Acinetobacter Infections - epidemiology | Catheter-Related Infections - microbiology | Adolescent | Gram-Negative Bacterial Infections - epidemiology | Bacteremia - epidemiology | Fungemia - epidemiology | Pediatrics | Burns and scalds | Health aspects | Diseases
Journal Article
International journal of antimicrobial agents, ISSN 0924-8579, 2009, Volume 34, Issue 1, pp. S2 - S7
Abstract Skin and soft tissue infections (SSTIs) are common and range in severity from minor, self-limiting, superficial infections to life-threatening diseases requiring all the resources of modern medicine... 
Infectious Disease | Community-acquired infections | Hospital infections | Staphylococci | Skin and soft tissue infections | Meticillin-resistant Staphylococcus aureus | Risk factors | Aetiology | INFECTIOUS DISEASES | ANTIBIOTICS | MANAGEMENT | PASTEURELLA-MULTOCIDA | GUIDELINES | MICROBIOLOGY | RESISTANT STAPHYLOCOCCUS-AUREUS | WOUND INFECTIONS | COMMUNITY | PANTON-VALENTINE LEUKOCIDIN | SURVEILLANCE | PHARMACOLOGY & PHARMACY | TOXIC-SHOCK-SYNDROME | Streptococcal Infections - microbiology | Skin Diseases, Bacterial - microbiology | Community-Acquired Infections - epidemiology | Staphylococcal Skin Infections - epidemiology | Bacterial Infections - drug therapy | Humans | Streptococcal Infections - epidemiology | Soft Tissue Infections - epidemiology | Soft Tissue Infections - microbiology | Staphylococcal Infections - epidemiology | Skin Diseases, Bacterial - epidemiology | Streptococcus - isolation & purification | Cross Infection - microbiology | Bacterial Infections - epidemiology | Staphylococcal Infections - microbiology | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Community-Acquired Infections - microbiology | Staphylococcal Skin Infections - microbiology | Bacterial Infections - microbiology | Cross Infection - epidemiology | Cross infection | Nosocomial infections | Microbiology | Health aspects | Epidemiology | Staphylococcus aureus infections
Journal Article
Antimicrobial agents and chemotherapy, ISSN 1098-6596, 2019, Volume 63, Issue 7
Bloodstream infection (BSI) organisms were consecutively collected from >200 medical centers in 45 nations between 1997 and 2016... 
NETWORK | CARE-ASSOCIATED INFECTIONS | ESCHERICHIA-COLI | VACCINE | MICROBIOLOGY | bloodstream infection | RESISTANT STAPHYLOCOCCUS-AUREUS | METHICILLIN-RESISTANT | antimicrobial resistance | BACTEREMIA | PHARMACOLOGY & PHARMACY | surveillance | ENGLAND | ENTEROBACTERIACEAE | HISTORY | Klebsiella pneumoniae - isolation & purification | Pseudomonas aeruginosa - isolation & purification | Enterococcus faecalis - drug effects | Klebsiella pneumoniae - drug effects | Community-Acquired Infections - epidemiology | Humans | Bacteremia - microbiology | Microbial Sensitivity Tests | Klebsiella Infections - epidemiology | Gram-Positive Bacterial Infections - microbiology | Acinetobacter baumannii - isolation & purification | Staphylococcal Infections - microbiology | Drug Resistance, Bacterial - drug effects | Acinetobacter Infections - microbiology | Latin America - epidemiology | Staphylococcus aureus - isolation & purification | Europe - epidemiology | Klebsiella Infections - microbiology | Pseudomonas aeruginosa - drug effects | Pseudomonas Infections - microbiology | Gram-Positive Bacterial Infections - epidemiology | Enterococcus faecalis - isolation & purification | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Acinetobacter Infections - epidemiology | Bacteremia - epidemiology | Anti-Bacterial Agents - pharmacology | Acinetobacter baumannii - drug effects | Staphylococcus aureus - drug effects | Community-Acquired Infections - microbiology
Journal Article
Clinical infectious diseases, ISSN 1537-6591, 2015, Volume 61, Issue suppl 2, pp. S69 - S78
Skin and soft-tissue infections (SSTIs) are an important cause of morbidity and mortality among hospitalized patients and a major therapeutic challenge for clinicians... 
telavancin | necrotizing infections | skin infections | cellulitis | soft-tissue infections | UNITED-STATES | INFECTIOUS DISEASES | HOSPITALIZED-PATIENTS | RISK-FACTORS | NECROTIZING FASCIITIS | CARE-ASSOCIATED INFECTIONS | MICROBIOLOGY | IMMUNOLOGY | COMPLICATED SKIN | STREPTOCOCCAL INFECTIONS | STAPHYLOCOCCUS-AUREUS INFECTIONS | SURGICAL SITE INFECTION | EPIDEMIOLOGY | Skin Diseases, Bacterial - microbiology | Humans | Skin Diseases, Bacterial - drug therapy | Oxazolidinones - therapeutic use | Gram-Negative Bacterial Infections - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Skin Diseases, Bacterial - epidemiology | Gram-Positive Bacterial Infections - microbiology | Soft Tissue Infections - drug therapy | Staphylococcal Infections - microbiology | Daptomycin - therapeutic use | Staphylococcal Infections - drug therapy | Methicillin-Resistant Staphylococcus aureus - drug effects | Gram-Negative Bacterial Infections - drug therapy | Clinical Trials as Topic | Soft Tissue Infections - epidemiology | Gram-Positive Bacterial Infections - epidemiology | Daptomycin - pharmacology | Soft Tissue Infections - microbiology | Staphylococcal Infections - epidemiology | Oxazolidinones - pharmacology | Gram-Negative Bacterial Infections - epidemiology | Anti-Bacterial Agents - pharmacology | North America - epidemiology | Aminoglycosides - pharmacology | Gram-Positive Bacterial Infections - drug therapy | Aminoglycosides - therapeutic use
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 2014, Volume 14, Issue 4, pp. 301 - 307
Journal Article
PloS one, ISSN 1932-6203, 2014, Volume 9, Issue 3, p. e91713
Background: While the majority of healthcare in the US is provided in community hospitals, the epidemiology and treatment of bloodstream infections in this setting is unknown... 
METHICILLIN-RESISTANT | MORTALITY | METAANALYSIS | MULTIDISCIPLINARY SCIENCES | ANTIMICROBIAL TREATMENT | VALIDATION | PREVENTION | STAPHYLOCOCCUS-AUREUS BACTEREMIA | ENDOCARDITIS | EPIDEMIOLOGY | SEVERITY | United States - epidemiology | Pseudomonas aeruginosa - isolation & purification | Community-Acquired Infections - epidemiology | Escherichia coli - drug effects | Humans | Middle Aged | Pseudomonas aeruginosa - growth & development | Drug Resistance, Bacterial | Male | Hospitals, Community | Bacteremia - microbiology | Gram-Negative Bacterial Infections - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Community-Acquired Infections - drug therapy | Female | Retrospective Studies | Staphylococcal Infections - microbiology | Escherichia coli - growth & development | Cross Infection - epidemiology | Medication Errors | Staphylococcal Infections - drug therapy | Staphylococcus aureus - isolation & purification | Bacteremia - drug therapy | Gram-Negative Bacterial Infections - drug therapy | Pseudomonas aeruginosa - drug effects | Cross Infection - drug therapy | Staphylococcal Infections - epidemiology | Escherichia coli - isolation & purification | Cross Infection - microbiology | Gram-Negative Bacterial Infections - epidemiology | Bacteremia - epidemiology | Aged | Staphylococcus aureus - drug effects | Staphylococcus aureus - growth & development | Community-Acquired Infections - microbiology | Health care | Therapy | Pediatrics | Communities | Physicians | Infections | Drug resistance | Epidemiology | Antiinfectives and antibacterials | Risk factors | Data dictionaries | 21st century | E coli | Trends | Nosocomial infections | Medical personnel | Pathogens | Coagulase | Comorbidity | Mortality | Staphylococcus infections | Antimicrobial agents | Risk analysis | Patients | Disease control | Studies | Infectious diseases | Hospitals | Endocarditis
Journal Article
Clinical infectious diseases, ISSN 1537-6591, 2009, Volume 48, Issue s4, pp. S231 - S237
Staphylococcus aureus is a major cause of bacteremia, and 5. aureus bacteremia is associated with higher morbidity and mortality, compared with bacteremia... 
Pathogens | Health outcomes | Antibiotics | Mortality | Endocarditis | Antibiotic resistance | Methicillin resistant staphylococcus aureus | Infections | Staphylococcus aureus | Bacteremia | UNITED-STATES | INFECTIOUS DISEASES | MICROBIOLOGY | IMMUNOLOGY | ANTIMICROBIAL RESISTANCE | METHICILLIN-RESISTANT | MEDICAL PROGRESS | VANCOMYCIN | PANTON-VALENTINE LEUKOCIDIN | HEMODIALYSIS-DEPENDENT PATIENTS | ANTIBIOTIC-TREATMENT | ENDOCARDITIS | BLOOD-STREAM INFECTIONS | Staphylococcal Infections - drug therapy | Cross Infection - economics | Community-Acquired Infections - epidemiology | Staphylococcus aureus - isolation & purification | Community-Acquired Infections - economics | Humans | Risk Factors | Bacteremia - drug therapy | Drug Resistance, Bacterial | Bacteremia - economics | Staphylococcus aureus - pathogenicity | Cross Infection - drug therapy | Bacteremia - microbiology | Methicillin-Resistant Staphylococcus aureus - pathogenicity | Health Care Costs | Staphylococcal Infections - epidemiology | Staphylococcal Infections - economics | Community-Acquired Infections - drug therapy | Cross Infection - microbiology | Bacteremia - epidemiology | Staphylococcal Infections - microbiology | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Community-Acquired Infections - microbiology | Cross Infection - epidemiology
Journal Article
Journal of Clinical Microbiology, ISSN 0095-1137, 06/2007, Volume 45, Issue 6, pp. 1705 - 1711
Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley... 
STRAINS | RISK-FACTORS | PANTON-VALENTINE LEUKOCIDIN | NARCOTIC ADDICTS | BACTEREMIA | GENES | MICROBIOLOGY | SKIN | PNEUMONIA | DETROIT-MEDICAL-CENTER | CHILDREN | Prevalence | Community-Acquired Infections - epidemiology | Humans | Middle Aged | Male | Methicillin - pharmacology | Case-Control Studies | Bacteremia - microbiology | Microbial Sensitivity Tests | Respiratory Tract Infections - microbiology | Anti-Bacterial Agents - therapeutic use | Staphylococcal Skin Infections - drug therapy | Community-Acquired Infections - drug therapy | Female | Soft Tissue Infections - drug therapy | Staphylococcal Infections - microbiology | Methicillin Resistance | Staphylococcus aureus - genetics | Staphylococcal Infections - drug therapy | Staphylococcal Skin Infections - epidemiology | Risk Factors | Bacteremia - drug therapy | Respiratory Tract Infections - drug therapy | Treatment Outcome | Soft Tissue Infections - epidemiology | Soft Tissue Infections - microbiology | Staphylococcal Infections - epidemiology | Molecular Epidemiology | Staphylococcus aureus - classification | Bacteremia - epidemiology | Anti-Bacterial Agents - pharmacology | Respiratory Tract Infections - epidemiology | Staphylococcus aureus - drug effects | Community-Acquired Infections - microbiology | Staphylococcal Skin Infections - microbiology | Epidemiology
Journal Article
International journal of antimicrobial agents, ISSN 0924-8579, 2012, Volume 39, Issue 4, pp. 273 - 282
Journal Article